CGK-1026

CAS No. 287383-59-9

CGK-1026 ( CGK 1026;CGK1026 )

Catalog No. M13877 CAS No. 287383-59-9

A small molecule that inhibits human telomerase reverse transcriptase (hTERT) expression.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 59 In Stock
10MG 88 In Stock
25MG 194 In Stock
50MG 357 In Stock
100MG 537 In Stock
500MG 1134 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    CGK-1026
  • Note
    Research use only, not for human use.
  • Brief Description
    A small molecule that inhibits human telomerase reverse transcriptase (hTERT) expression.
  • Description
    A small molecule that inhibits human telomerase reverse transcriptase (hTERT) expression; inhibits the recruitment of HDAC into E2F-pocket protein complexes assembled on the hTERT promoter, inhibits HDAC activity with IC50 of 100 nM; induces G1 arrest of IMR90 cells.
  • Synonyms
    CGK 1026;CGK1026
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    HDAC
  • Recptor
    HDAC
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    287383-59-9
  • Formula Weight
    326.35
  • Molecular Formula
    C18H18N2O4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 32.6 mg/mL (100 mM) ( < 1 mg/ml refers to the product slightly soluble or insoluble )
  • SMILES
    O=C(NO)CCCCCN(C(C1=CC=CC2=CC=CC3=C12)=O)C3=O
  • Chemical Name
    N-Hydroxy-1,3-dioxo-1H-benz[de]isoquinoline-2(3H)-hexanamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Won J, et al. Proc Natl Acad Sci U S A. 2004 Aug 3;101(31):11328-33.
2. Alimirah F, et al. Mol Cancer Res. 2007 Mar;5(3):251-9.
3. Song LL, et al. PLoS One. 2010 Jan 5;5(1):e8569.
molnova catalog
related products
  • Ledipasvir

    Ledipasvir is a Hepatitis C Virus NS5A Inhibitor. The mechanism of action of ledipasvir is as a P-Glycoprotein Inhibitor, and Breast Cancer Resistance Protein Inhibitor.

  • BRD 8184

    BRD 8184 is a potent, selective HDAC6 inhibitor with IC50 of 8 nM.

  • T247

    A potent and selective HDAC3 inhibitor with IC50 of 0.24 uM, >75-fold selectivity over HDAC1 and no activity against HDAC4/6/8.